AAP
BSX icon

Aristotle Atlantic Partners’s Boston Scientific BSX Stock Holding History

Aristotle Atlantic Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Sell
25,400
-198,120
-89% -$10.8M 0.04% 87
2026
Q1 		$14M Buy
223,520
+12,480
+6% +$998K 0.66% 44
2025
Q4 		$20.1M Sell
211,040
-6,242
-3% -$612K 0.92% 37
2025
Q3 		$21.2M Sell
217,282
-9,700
-4% -$1M 0.62% 39
2025
Q2 		$24.4M Sell
226,982
-7,557
-3% -$765K 0.74% 36
2025
Q1 		$23.7M Buy
234,539
+8,355
+4% +$841K 0.8% 36
2024
Q4 		$20.2M Sell
226,184
-14,358
-6% -$1.26M 0.64% 38
2024
Q3 		$20.2M Buy
240,542
+7,333
+3% +$578K 0.63% 42
2024
Q2 		$18M Buy
+233,209
New +$17.1M 0.58% 48

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Aristotle Atlantic Partners's BSX Position: Q2 2026 in Review

Aristotle Atlantic Partners reduced its Boston Scientific (BSX) stake by 89% in Q2 2026, selling an estimated $10.8M and leaving 25,400 shares worth $1.08M. The position accounts for 0.04% of the portfolio, ranked #87.

Aristotle Atlantic Partners first reported a position in BSX in Q2 2024 and has held it in 9 quarters since. The position peaked at $24.4M in Q2 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Aristotle Atlantic Partners held 25,400 shares of Boston Scientific worth $1.08M as of Q2 2026.
  • Aristotle Atlantic Partners sold 198,120 Boston Scientific shares in Q2 2026, an estimated $10.8M.
  • Boston Scientific made up 0.04% of Aristotle Atlantic Partners's portfolio in Q2 2026, its #87 holding.
  • Aristotle Atlantic Partners first reported a position in Boston Scientific in Q2 2024 and has held it in 9 quarters since.
  • Aristotle Atlantic Partners's Boston Scientific position peaked at $24.4M in Q2 2025.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Aristotle Atlantic Partners's 13F filing for Q2 2026, filed 14 Aug 2026.